SCHEMBL30976401

SCHEMBL30976401

COc1ccc(N2CCN(C(=O)c3nn(-c4cc(OC)cc(OC)c4)c(=O)c4ccccc34)CC2)cc1

nearest known ligand 0.74

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 1/20 0.74
▸ TSHR P16473 1/20 0.73
▸ ALDH1A1 P00352 6/20 0.69
▸ KMT2A Q03164 4/20 0.69
▸ MEN1 O00255 3/20 0.69
▸ NPSR1 Q6W5P4 2/20 0.69
▸ HPGD P15428 2/20 0.69
▸ USP2 O75604 1/20 0.69
▸ KDM4E B2RXH2 3/20 0.68
▸ POLB P06746 2/20 0.61
▸ SMN1; SMN2 Q16637 2/20 0.60
▸ THRB P10828 1/20 0.59
▸ L3MBTL1 Q9Y468 1/20 0.59
▸ LMNA P02545 2/20 0.57
▸ MAPT P10636 1/20 0.57
▸ NPC1 O15118 2/20 0.55
▸ RAB9A P51151 2/20 0.55
▸ TP53 P04637 1/20 0.55
▸ GAA P10253 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31199208 0.95 TSHR (0.74) HTTTSHRALDH1A1KMT2AMEN1
SCHEMBL30976282 0.95 HTT (0.82) HTTTSHRALDH1A1KMT2AMEN1
SCHEMBL30976269 0.93 ALDH1A1 (0.77) HTTTSHRALDH1A1KMT2AMEN1
SCHEMBL30976290 0.92 ALDH1A1 (0.72) HTTTSHRALDH1A1KMT2AMEN1
SCHEMBL30976279 0.90 ALDH1A1 (0.78) HTTTSHRALDH1A1KMT2AMEN1
SCHEMBL30976373 0.88 L3MBTL1 (0.77) HTTTSHRALDH1A1KMT2AMEN1
SCHEMBL30976425 0.88 TSHR (0.68) HTTTSHRALDH1A1KMT2AMEN1
SCHEMBL30976262 0.87 HTT (0.70) HTTTSHRALDH1A1KMT2AMEN1
SCHEMBL30976337 0.87 KMT2A (0.90) HTTTSHRALDH1A1KMT2AMEN1
SCHEMBL30976523 0.87 NPSR1 (0.81) HTTTSHRALDH1A1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4619387-A1 PHTHALAZINONE BASED MODULATORS FOR THE TREATMENT OF DISEASE Soley Therapeutics, Inc. (US) 2025-09-24 — — EP disclosed
WO-2024108131-A1 PHTHALAZINONE BASED MODULATORS FOR THE TREATMENT OF DISEASE SOLEY THERAPEUTICS, INC. (US) 2024-05-23 — — WO disclosed
Send feedback